Show simple item record

dc.contributor.advisorNigel, Lindsey
dc.contributor.authorRowton, Sharon*
dc.date.accessioned2010-05-10T15:31:56Z
dc.date.available2010-05-10T15:31:56Z
dc.date.issued2010-05-10T15:31:56Z
dc.identifier.urihttp://hdl.handle.net/10454/4293
dc.description.abstractMultiple sclerosis is a complex disease and one for which the aetiology remains largely unanswered. Anti-dsDNA antibodies have been found intrathecally and bordering lesions in multiple sclerosis patients and in view of their known pathogenity in lupus nephritis the aim of this project was to further investigate their role in multiple sclerosis. Using the acute experimental allergic encephalomyelitis (EAE) model in the Lewis rat, the inflammatory phase of disease was profiled using immunohistological and ELISA methods and was related to clinical sign severity. The parameters of interest were central nervous system deposits of IgM, IgG, B cells and C3 and anti-DNA antibodies in sera, cerebrospinal fluid and in situ. In situ evaluation of anti-dsDNA antibodies was also performed in tissue taken from Biozzi (AH) mice (relapsing/remitting EAE model) and from a multiple sclerosis patient. Inflammatory deposits specifically at sites of perivascular cuffing were found to increase with increasing clinical sign severity. At the time clinical signs had plateaued in the Lewis rat, intrathecal anti-dsDNA antibodies were at their highest level and anti-ssDNA antibodies at their lowest. The latter possibly due to their involvement in the `clearing-up¿ process following tissue damage. Using novel DNA probes fluorescence suggestive of the presence of anti-dsDNA iii antibodies was seen in both animal and human tissue. Within human tissue the antibodies appeared to accumulate around active lesions and within vessels, raising the question of these antibodies having differing location dependent functions. EAE models have the potential to investigate these findings further and to evaluate new therapies.en
dc.description.sponsorshipCovance Laboratories Ltd.en
dc.language.isoenen
dc.rights<a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="Creative Commons License" style="border-width:0" src="http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png" /></a><br />The University of Bradford theses are licenced under a <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Licence</a>.en
dc.subjectEAEen
dc.subjectdsDNAen
dc.subjectAntibodiesen
dc.subjectAlexa Fluoren
dc.subjectDAPIen
dc.subjectMultiple sclerosisen
dc.titlePathological role of double-stranded DNA antibodies in multiple sclerosis.en
dc.type.qualificationleveldoctoralen
dc.publisher.institutionUniversity of Bradfordeng
dc.publisher.departmentDivision of Biomedical Sciencesen
dc.typeThesiseng
dc.type.qualificationnamePhDen
dc.date.awarded2009
refterms.dateFOA2018-07-18T23:40:49Z


Item file(s)

Thumbnail
Name:
Cover_SRowton.pdf
Size:
8.584Kb
Format:
PDF
Description:
Cover
Thumbnail
Name:
PhD thesis_SROWTON.pdf
Size:
3.637Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record